OPDIVO QVANTIG
NDC 0003-3120, nivolumab and hyaluronidase-nvhy, injection, solution, from E.R. Squibb & Sons, L.L.C..
- Product NDC
- 0003-3120
- Status
- Listed
- Labeler
- E.R. Squibb & Sons, L.L.C.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761381
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0003-3120 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NIVOLUMAB120 mg/mL
- HYALURONIDASE (HUMAN RECOMBINANT)2000 U/mL
Pharmacologic classes
Endoglycosidase [EPC]; Glycoside Hydrolases [CS]; Programmed Death Receptor-1 Blocking Antibody [EPC]; Programmed Death Receptor-1-directed Antibody Interactions [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0003-3120-01 | 00003312001 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0003-3120-01) / 2.5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7f8c38fa-42f4-4387-9e8c-7a1c66855d8bMedicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0003-3120
Use it
Look up 0003-3120 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0003-3120 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0003-3120. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.